Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CASKIN1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | CARMIL2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
mRNA | TRIM73 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | VPS26A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | ERRFI1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | TUFT1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | EXOSC8 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ABCC8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | KATNAL2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | TMEM189-UBE2V1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |